Oregon Health Authority

Oregon Health Authority Buried Report Proving Higher Taxes Don’t Curb Excessive Alcohol Use

Retrieved on: 
Friday, January 26, 2024
Addiction, Beer, Bias, Mental health, Wine, Oregon Health Authority, Task force, News, Recycling

PORTLAND, Ore., Jan. 26, 2024 (GLOBE NEWSWIRE) -- The Oregonian reported breaking investigative news the Oregon Health Authority appears to have intentionally withheld a publicly funded report that contradicted its position on alcohol tax increases.

Key Points: 
  • PORTLAND, Ore., Jan. 26, 2024 (GLOBE NEWSWIRE) -- The Oregonian reported breaking investigative news the Oregon Health Authority appears to have intentionally withheld a publicly funded report that contradicted its position on alcohol tax increases.
  • The report by reputable Oregon economists and researchers from EcoNorthwest, which should have been published in 2021, found alcohol taxes “are far less likely to reduce consumption in heavy and excessive drinkers.” The Oregon Beverage Alliance issued the following statement:
    “This shocking news is deeply concerning that the Oregon Health Authority appears to have intentionally buried a taxpayer-funded study it commissioned because the findings contradicted efforts to justify raising alcohol taxes,” said the Oregon Beverage Alliance.
  • “As the Task Force on Alcohol Pricing and Addiction Services prepares to hear more potential bias and inaccuracies from Oregon Health Authority at the upcoming, Feb. 1, meeting, how can members trust the information Oregon Health Authority is providing to stakeholders and policymakers?
  • If Oregon Health Authority, and possibly others, knew about the report findings in 2021, and yet continued to advocate that increasing alcohol taxes would reduce consumption for problem drinkers, this appears deceptive and we demand answers.

Constitutional Concerns Arise as Psilocybin Trainer Challenges Oregon Requirements

Retrieved on: 
Wednesday, December 6, 2023
Communication, Psilocybin, HECC, Ambiguity, Licensure, Oregon Health Authority, OHA, Curriculum, Constitution, Nursing, SALEM

SALEM, Ore., Dec. 6, 2023 /PRNewswire-PRWeb/ -- Shasta Winn, the creator of the Myco-Method psilocybin facilitator training program, has officially filed a formal complaint against the Oregon Higher Education Coordinating Commission (HECC), bringing attention to constitutional violations and regulatory ambiguities in their decision-making process. Simultaneously, the Oregon Health Authority (OHA) is in the process of deliberating whether to amend existing regulations, making HECC licensure a requirement for OHA-approved psilocybin training programs.

Key Points: 
  • Shasta Winn, creator of the Myco-Method psilocybin training, files a formal complaint against the Oregon Higher Education Coordinating Commission (HECC).
  • Winn highlights concerns about substantive due process, equal protection, and religious rights, urging reconsideration and clarification from HECC.
  • Simultaneously, the Oregon Health Authority (OHA) is in the process of deliberating whether to amend existing regulations, making HECC licensure a requirement for OHA-approved psilocybin training programs.
  • The broader implications for constitutional and religious rights, as well as potential legal consequences, further underscore the urgency for a comprehensive review of the HECC licensure process.

National Medical Fellowships Announces Inaugural 50 Recipients of the Future Clinicians Scholarship Program Made Possible by the United Health Foundation

Retrieved on: 
Wednesday, November 15, 2023
DREAM, Medicine, Health equity, UnitedHealth Group, Nursing, Student, Pharmacy, Male, National Medical Fellowships, Health, Oregon Health Authority, Partnership, NMF, Social work, Female, Dentistry

ALEXANDRIA, Va., Nov. 15, 2023 /PRNewswire/ -- National Medical Fellowships (NMF) announces the Future Clinicians Scholarship Program , an initiative designed to support and empower diverse health care leaders in the United States.

Key Points: 
  • ALEXANDRIA, Va., Nov. 15, 2023 /PRNewswire/ -- National Medical Fellowships (NMF) announces the Future Clinicians Scholarship Program , an initiative designed to support and empower diverse health care leaders in the United States.
  • Career Paths: While 70% of awarded scholars are pursuing medical degrees, the Future Clinicians Scholarship Program also supports those seeking advanced degrees in various health care disciplines.
  • "NMF extends its deepest appreciation to the United Health Foundation for its generous support in making the Future Clinicians Scholarship Program a reality.
  • For more information about the Future Clinicians Scholarship Program and other initiatives by National Medical Fellowships, please visit https://nmfonline.org/scholarships/future-clinicians-scholarship-program/ .

Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game

Retrieved on: 
Thursday, October 19, 2023
Post-traumatic stress disorder, Big Pharma, FDA, CAD, KAYS, Patent, Food, Oregon Health Authority, Therapy, Sacredness, COMPASS, DSM-IV codes, News, Pharma, FDT, US Foods, Research, Initial, OTCQB, Psilocybin, Yoga, Breakthrough therapy, Private placement, Good, Ōtsuka, Eating, Anorexia nervosa, Depression, OHA, Medication, Anxiety, Investment, Patient, Neuropsychiatry, TRD, Pulse, Mental health, Pharmaceutical industry, Nursing

As psilocybin and other alternative health innovators try to shape the future of mental health, Pharma and traditional healthcare investors are watching and waiting to get their share.

Key Points: 
  • As psilocybin and other alternative health innovators try to shape the future of mental health, Pharma and traditional healthcare investors are watching and waiting to get their share.
  • (OTCQB: KAYS) is the only U.S. public company engaged in securing an Oregon Health Authority ("OHA") license to open a psilocybin treatment center.
  • Kaya Holdings just announced that it has closed an additional round of bridge financing targeted to complete KAYS' planned psilocybin treatment center in Portland, Oregon.
  • Reporting on the Mindset Pharma deal, Psychedelicspotlight.com said , "Big Pharma has certainly taken note of the potential therapeutic benefits of psychedelics.

The Inner Circle Acknowledges, Jaqueline M. DeSilva, RN as a Top Pinnacle Healthcare Professional for her contributions to the field of Pain Management

Retrieved on: 
Monday, August 21, 2023
Randolph, Travel, University, Moses Austin, Education, Asante Three Rivers Medical Center, Business, Ujan Ganger Naiya, Trauma, MBA, Emergency department, BSN, Oregon Health Authority, Inner circle, EMS, Business administration, Quantic School of Business and Technology, Walking, Pain management, RN, Clinical, Randolph Community College, Nursing

MEDFORD, Ore., Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jaqueline M. DeSilva, RN is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the field of Pain Management.

Key Points: 
  • MEDFORD, Ore., Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jaqueline M. DeSilva, RN is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the field of Pain Management.
  • She is also slated to complete Executive Master of Business Administration program at Quantic School of Business and Technology in February 2024.
  • Ms. DeSilva is the CEO of Pain Specialists of Southern Oregon and Crater Lake Surgery Center, currently managing two clinics and an ambulatory surgery center.
  • She entered the field of nursing working at Randolph Community Hospital in Asheboro, NC in 2000.

Fluence Announces Graduation of First Cohort of Students in Certificate in Psilocybin-Assisted Therapy

Retrieved on: 
Thursday, August 10, 2023
Psilocybin, LCSW, NCC, Integration, Curriculum, Psychotherapy, Oregon Higher Education Coordinating Commission, History, Doctor of Philosophy, Oregon Health Authority, Science, Social, Oregon Health and Science University Center for Women's Health, Student, Physician, Nursing, 2020 Oregon Ballot Measure 109, Knowledge, Addiction, Trauma, Mental health, LPC, OPS, Counselor, Satellite navigation device, Radiant exposure

PORTLAND, Ore., Aug. 10, 2023 /PRNewswire-PRWeb/ -- Fluence, a leading psychedelic therapy training organization, today announced the graduation of the first cohort of students in its Certificate in Psilocybin-Assisted Therapy. The 9-month training program, which launched in November 2022, provides students with the knowledge and skills they need to provide psilocybin sessions under Oregon's Measure 109.

Key Points: 
  • PORTLAND, Ore., Aug. 10, 2023 /PRNewswire-PRWeb/ -- Fluence , a leading psychedelic therapy training organization, today announced the graduation of the first cohort of students in its Certificate in Psilocybin-Assisted Therapy .
  • The 9-month training program, which launched in November 2022, provides students with the knowledge and skills they need to provide psilocybin sessions under Oregon's Measure 109.
  • The program is grounded in Fluence's Psychedelic Harm Reduction and Integration (PHRI) approach to psychedelic-assisted therapy and integration.
  • It is designed and taught by leading experts with psilocybin-assisted therapy experience in clinical research settings.

Satya Inc. Announces the Leasing of a Facility in Jackson County, Oregon, and the Submission of an Application for an Oregon Psilocybin Product Manufacturer License

Retrieved on: 
Wednesday, February 1, 2023
Alternative Medicine, Lifestyle, Health, Consumer, Women, General Health, Men, Psilocybin, OHA, Oregon Health Authority, Satya, Ecosystem, United, Fungus, Inc., The Company, Property management

Satya Inc. (or the "Company") is pleased to announce that it has leased a facility in Jackson County, Oregon, and submitted a license application for an Oregon Psilocybin Product Manufacturer license with endorsements for fungi cultivation, psilocybin extraction, and edible psilocybin production.

Key Points: 
  • Satya Inc. (or the "Company") is pleased to announce that it has leased a facility in Jackson County, Oregon, and submitted a license application for an Oregon Psilocybin Product Manufacturer license with endorsements for fungi cultivation, psilocybin extraction, and edible psilocybin production.
  • Effective December 31, 2022, the Company entered into a Commercial Lease Agreement for a 4,000 square foot facility in Jackson County, Oregon.
  • The Company has commenced the build-out of its proposed licensed premises at the facility, which it expects to complete by May 2023.
  • On January 3, 2023, Jackson County approved a Land Use Compatibility Statement (LUCS) for the proposed site.

Comagine Health Bolsters Leadership Team with Additional Members

Retrieved on: 
Thursday, January 12, 2023
Oregon Health Authority, Evaluation, Publication, Accounting, LMSW, Government, Korea Disease Control and Prevention Agency, Research, Marketing, Policy, Growth, Patient, MBA, National Center for Research on Evaluation, Standards, and Student Testing, CDC, NIH, CADC, Management, Health

SEATTLE, Jan. 12, 2023 /PRNewswire-PRWeb/ -- Comagine Health, a leading national nonprofit health care consulting firm, named additional leaders recently. Marc Bennett, Comagine Health's president and chief executive officer, recognized that a broader range of diverse expertise is needed at the leadership level to achieve the organization's mission and vision. This move supports Comagine Health's commitment to investing in the research and evaluation division and enhancing the growth division.

Key Points: 
  • SEATTLE, Jan. 12, 2023 /PRNewswire-PRWeb/ -- Comagine Health, a leading national nonprofit health care consulting firm, named additional leaders recently.
  • "Comagine Health is committed to reimagining health care, together," Bennett said.
  • Comagine Health continues to expand, and our growth division has contributed significantly to much of this expansion.
  • Funders include the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH) and the Oregon Health Authority.

More Than 10 Million Adults Already Affected by "Tridemic"; Real-Time Oxygen Saturation Monitoring of At-Risk Patients Can Help Prevent Adverse Events

Retrieved on: 
Thursday, December 15, 2022
Oregon Health Authority, Physician, AT&T, MD, ICU, Health, Patient, COVID, Death, Respiratory system, Remote patient monitoring, FDA, COVID-19, Degenerative disease, RSV, Smart meter, CDC, Risk, Hospital

With Smart Meter's iPulseOx, the world's first cellular-enabled pulse oximeter, providers can instantly see a person's oxygen saturation level and take steps necessary to help prevent adverse events.

Key Points: 
  • With Smart Meter's iPulseOx, the world's first cellular-enabled pulse oximeter, providers can instantly see a person's oxygen saturation level and take steps necessary to help prevent adverse events.
  • The CDC has recorded at least 8.7 million cases of flu, including 78,000 hospitalizations and 4,500 deaths, since October, according to published reports.
  • Each year, it is estimated that between 60,000-120,000 older adults in the United States are hospitalized and 6,000-10,000 of them die due to RSV infection1.
  • When a physician has real-time oxygen saturation readings, they can make immediate decisions regarding their patients.

Fentanyl Drives Fatal Overdoses to Over 107,000 Annually in the U.S. - Healthcare Providers' Effort to Fight Back

Retrieved on: 
Wednesday, August 24, 2022
Fentanyl, Homelessness, Research, Opioid use disorder, Drug, MAT, Risk assessment, Society, Sexual abuse, ASAM, Shame, Health, Asthma, Pain management, Prescription, Oregon Health Authority, Quality of life, Organization, Center, Transitive dependency, GLOBE, Patient, Hypertension, Substance use disorder, SUD, Stigma, Pharmacy, Korea Disease Control and Prevention Agency, Addiction medicine, Oregon Health Plan, McWilliams, Risk, Diabetes, American Society of Addiction Medicine, Naloxone, CDC, Pharmaceutical industry, Risk management, Equinox

American Society of Addiction Medicine (ASAM) encourages the co-prescribing of naloxone for people at risk of overdose , including those diagnosed with and being treated for opioid use disorder.

Key Points: 
  • American Society of Addiction Medicine (ASAM) encourages the co-prescribing of naloxone for people at risk of overdose , including those diagnosed with and being treated for opioid use disorder.
  • "If they say yes, 95% of them will say someone has given them naloxone."
  • Often, the drugs being consumed are a mixture of a variety of illicit substances, including fentanyl.
  • "Unfortunately, in the past there has been the misconception that naloxone was a medication that enabled drug abuse.